TWI736818B - Extract from golden eye-grass (curculigo orchioides) and use in preparation of composition having activities of skin whitening and protecting dna - Google Patents

Extract from golden eye-grass (curculigo orchioides) and use in preparation of composition having activities of skin whitening and protecting dna Download PDF

Info

Publication number
TWI736818B
TWI736818B TW107146665A TW107146665A TWI736818B TW I736818 B TWI736818 B TW I736818B TW 107146665 A TW107146665 A TW 107146665A TW 107146665 A TW107146665 A TW 107146665A TW I736818 B TWI736818 B TW I736818B
Authority
TW
Taiwan
Prior art keywords
extract
equivalent
butanol
ethyl acetate
extraction layer
Prior art date
Application number
TW107146665A
Other languages
Chinese (zh)
Other versions
TW202023527A (en
Inventor
梁家華
Original Assignee
嘉藥學校財團法人嘉南藥理大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 嘉藥學校財團法人嘉南藥理大學 filed Critical 嘉藥學校財團法人嘉南藥理大學
Priority to TW107146665A priority Critical patent/TWI736818B/en
Publication of TW202023527A publication Critical patent/TW202023527A/en
Application granted granted Critical
Publication of TWI736818B publication Critical patent/TWI736818B/en

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to an extract from Golden eye-grass (Curculigo orchioides) and a use thereof. The Golden eye-grass extract has activities of skin whitening and protecting DNA, so that it can be added as an effective ingredient in a composition for skin whitening and protecting DNA.

Description

仙茅萃取物用於製備具有皮膚美白及保護DNA活性之組成物的用途 The use of Curculigo extract for the preparation of a composition with skin whitening and DNA protection activity

本發明係有關於一種植物萃取物的用途,特別是有關於一種仙茅萃取物用於製備具有皮膚美白及保護DNA活性之組成物的用途。 The present invention relates to the use of a plant extract, in particular to the use of a curculus extract to prepare a composition with skin whitening and DNA protection activities.

目前已知紫外線會使皮膚出現皺紋、色素斑,甚至造成細胞老化、癌化或死亡。紫外線(ultraviolet;UV)或反應性含氧物種(reactive oxygen species;ROS)是造成自由基大量產生的因素之一,自由基的活性高且不穩定,過多的自由基會和體內的細胞組織產生氧化反應。紫外線增加人體自由基的活性後,在一般的狀況下,人體具有修復能力。惟過量的紫外線使得自由基大量產生,導致組織細胞失去正常功能,甚至破壞DNA,使細胞DNA修復能力降低,而造成損害或突變,進而引發癌症。 It is currently known that ultraviolet rays can cause wrinkles and pigment spots on the skin, and even cause cell aging, cancerization or death. Ultraviolet (ultraviolet; UV) or reactive oxygen species (reactive oxygen species; ROS) is one of the factors that cause a large number of free radicals. The activity of free radicals is high and unstable. Too many free radicals will be produced with the cell tissue in the body Oxidation reaction. After ultraviolet rays increase the activity of free radicals in the human body, under normal conditions, the human body has the ability to repair. However, excessive ultraviolet rays cause a large number of free radicals to be produced, causing tissue cells to lose their normal functions, and even damage DNA, reducing the cell's DNA repair ability, causing damage or mutations, and then causing cancer.

仙茅(Golden eye-grass;Kali musli,Syah musli;Weevil-wort;Xian mao;Curculigo orchioides),又名地棕根、地棕、獨茅根、獨茅、獨腳仙茅、山黨參、仙茅參、海南參、婆羅門參或芽瓜子,其為石蒜科仙茅屬多年生草本植物。分布於印度尼西亞、日本、東南亞、台灣島以及中國大陸的廣西、廣東、貴州、福建、雲南、浙江、四川、湖南、江西等地。仙茅已知有護肝、抗癌、免疫調節、抗糖尿病、傷口治癒及抗氣喘的活性。 Curculigo (Golden eye-grass; Kali musli, Syah musli; Weevil-wort; Xian mao; Curculigo orchioides ), also known as ground brown roots, ground brown, single-grass roots, single-grass, single-leg curculus, codonopsis, curculigo Ginseng, Hainan ginseng, salsify or bud melon seeds, which are perennial herbs of the genus Curculio Amaryllidaceae. Distributed in Indonesia, Japan, Southeast Asia, Taiwan Island and China's Guangxi, Guangdong, Guizhou, Fujian, Yunnan, Zhejiang, Sichuan, Hunan, Jiangxi and other places. Curculigo is known to have liver protection, anti-cancer, immune regulation, anti-diabetic, wound healing and anti-asthmatic activities.

惟目前並無文獻證實仙茅萃取物是否具有皮膚美白及保護DNA之活性。有鑑於此,亟需提供一種仙茅萃取物的新用途,以拓展其應用面。 However, there is currently no document confirming whether Curculio vulgaris extract has skin whitening and DNA protection activities. In view of this, there is an urgent need to provide a new use of Curculio extract to expand its application.

因此,本發明之一態樣是提供一種仙茅(Curculigo orchioides)萃取物用於製備具有皮膚美白及保護DNA活性之組成物的用途。 Therefore, one aspect of the present invention is to provide a use of Curculigo orchioides extract for preparing a composition with skin whitening and DNA protection activities.

本發明之另一態樣為提供一種仙茅萃取物,其係透過至少一次的分配萃取步驟獲得。上述之仙茅萃取物包含粗萃物、正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物之任一種或其任意組合。 Another aspect of the present invention is to provide a curculio extract obtained through at least one distribution extraction step. The aforementioned Curculio extracts include any one or any combination of crude extracts, n-hexane extracts, ethyl acetate extracts, and n-butanol extracts.

本發明之另一態樣為提供一種組成物,此組成物包含利用上述之至少一次的分配萃取步驟所獲得之仙茅萃取物。 Another aspect of the present invention is to provide a composition comprising a curculio extract obtained by the above-mentioned at least one partition extraction step.

根據本發明之上述之態樣,提出一種仙茅萃取物用於製備具有皮膚美白及保護DNA活性之組成物的用 途,上述之仙茅萃取物係利用低級醇溶液對仙茅之塊根或根莖(rhizomes)進行粗萃步驟以獲得粗萃物,塊根或根莖與低級醇溶液之重量體積比(g:mL)為1:500至1:1000,且低級醇溶液為甲醇溶液或乙醇溶液。 According to the above aspect of the present invention, a curculus extract is proposed for the preparation of a composition with skin whitening and DNA protection activities. In this way, the above-mentioned Curculio vulgaris extract uses a lower alcohol solution to perform a rough extraction step on the roots or rhizomes of Curculigo to obtain the crude extract. The weight-volume ratio (g:mL) of the roots or rhizomes to the lower alcohol solution is 1:500 to 1:1000, and the lower alcohol solution is methanol solution or ethanol solution.

依據本發明上述之實施例,上述之仙茅萃取物係利用正己烷對粗萃物進行第一分配萃取步驟,以獲得正己烷萃取層及水萃取層,其中正己烷萃取層具有正己烷萃取物。 According to the above-mentioned embodiment of the present invention, the above-mentioned curculio extract uses n-hexane to perform the first distribution extraction step on the crude extract to obtain a n-hexane extraction layer and a water extraction layer, wherein the n-hexane extraction layer has a n-hexane extract .

依據本發明上述之實施例,上述之仙茅萃取物係利用乙酸乙酯對水萃取層進行第二分配萃取步驟,以獲得乙酸乙酯萃取層,其中乙酸乙酯萃取層具有乙酸乙酯萃取物。 According to the above-mentioned embodiment of the present invention, the above-mentioned curculio extract uses ethyl acetate to perform the second distributive extraction step on the water extraction layer to obtain an ethyl acetate extraction layer, wherein the ethyl acetate extraction layer has an ethyl acetate extract .

依據本發明上述之實施例,上述之仙茅萃取物係利用正丁醇對水萃取層進行第三分配萃取步驟,以獲得正丁醇萃取層,其中正丁醇萃取層具有正丁醇萃取物。 According to the above-mentioned embodiment of the present invention, the above-mentioned curculio extract uses n-butanol to perform the third distributive extraction step on the water extraction layer to obtain the n-butanol extraction layer, wherein the n-butanol extraction layer has the n-butanol extract .

根據本發明之另一態樣,其係利用上述之至少一次的分配萃取步驟所獲得之仙茅萃取物作為美白活性成份的應用,此仙茅萃取物之美白活性的有效劑量為25μg/mL至50μg/mL。 According to another aspect of the present invention, which system using the application of curculin extract obtained in the extraction step as the whitening active ingredient at least one of the dispensing, an effective dose of whitening activity of this extract is Curculigo 25 μ g / mL to 50 μ g / mL.

根據本發明之另一態樣,其係利用上述之至少一次的分配萃取步驟所獲得之仙茅萃取物作為保護DNA活性成份的應用,此仙茅萃取物之保護DNA活性的有效劑量為100μg/mL至500μg/mL。 According to another aspect of the present invention, the curculus extract obtained by the above-mentioned distributive extraction step at least once is used as an application to protect the active ingredients of DNA, and the effective dose of the curculus extract to protect the DNA activity is 100 μ g / mL to 500 μ g / mL.

根據本發明之又一態樣,其係應用上述之仙茅萃取物作為組成物,其中此組成物為化妝品組成物或醫藥組成物。 According to another aspect of the present invention, the above-mentioned Curculigo extract is used as a composition, wherein the composition is a cosmetic composition or a pharmaceutical composition.

為讓本發明之上述和其他目的、特徵、優點與實施例能更明顯易懂,所附圖式之詳細說明如下:〔圖1A〕係繪示根據本發明一實施例之仙茅萃取物對於細胞內蘑菇酪胺酸酶活性之直條圖。 In order to make the above and other objectives, features, advantages and embodiments of the present invention more comprehensible, the detailed description of the accompanying drawings is as follows: [FIG. 1A] is a diagram showing the effect of Curculio vulgaris extract according to an embodiment of the present invention Bar graph of mushroom tyrosinase activity in cells.

〔圖1B〕係繪示根據本發明一實施例之仙茅萃取物降低細胞內黑色素含量之直條圖。 [Fig. 1B] is a bar graph showing the reduction of melanin content in cells by Curculio vulgaris extract according to an embodiment of the present invention.

〔圖2A〕為顯示在過氧化氫(H2O2)及UVB的處理下,仙茅萃取物保護DNA之核酸電泳圖。 [Figure 2A] is a nucleic acid electrophoresis diagram showing the protection of DNA from Curculio vulgaris extract under the treatment of hydrogen peroxide (H 2 O 2) and UVB.

〔圖2B〕係繪示圖2A各組之超螺旋型DNA及開環型DNA的螢光強度比之直條圖。 [Figure 2B] is a bar graph showing the fluorescence intensity ratio of the supercoiled DNA and the open-circular DNA of each group in Figure 2A.

〔圖3A〕係繪示根據本發明一實施例之仙茅萃取物與HaCaT細胞共培養的細胞存活率之直條圖。 [Fig. 3A] is a bar graph showing the survival rate of cells co-cultured with Curculio vulgaris extract and HaCaT cells according to an embodiment of the present invention.

〔圖3B〕係繪示根據本發明一實施例之仙茅萃取物與B16F10細胞共培養的細胞存活率之直條圖。 [Figure 3B] is a bar graph showing the survival rate of cells co-cultured with Curculio vulgaris extract and B16F10 cells according to an embodiment of the present invention.

〔圖4〕係繪示本發明一實施例之仙茅萃取物於體外一氧化氮(NO)自由基的清除率之直條圖。 [Figure 4] is a bar graph showing the in vitro nitric oxide (NO) free radical scavenging rate of Curculio vulgaris extract of an embodiment of the present invention.

承上所述,本發明提供一種仙茅萃取物用於製備具有皮膚美白及保護DNA活性之組成物的用途,此仙茅萃取物係利用低級醇溶液對仙茅(Curculigo orchioides)之塊根或根莖(rhizomes)進行粗萃步驟所獲得。 The bearing, the present invention provides a method for the manufacture curculin extract having skin whitening composition of the active material and the protection of DNA, this curculin extract was based on the use of a lower alcohol solution Hypoxidaceae (Curculigo orchioides) of the root or rhizome (rhizomes) are obtained by the crude extraction step.

此處所稱的低級醇溶液可例如碳數不超過3之醇類溶液,可選擇性地為甲醇溶液或乙醇溶液。在一實施例中,在進行粗萃步驟時,於不高於室溫(例如10℃至40℃)下粉碎仙茅(Curculigo orchioides)塊根或根莖。接著,將粉碎的仙茅塊根或根莖加入低級醇溶液萃取後,使用紗布、濾紙、離心或其他習知方式過濾一或數次去除殘渣,以獲得濾液。在此實施例中,塊莖與低級醇溶液之重量體積比(g:mL)為1:500至1:1000。 The lower alcohol solution referred to herein may be, for example, an alcohol solution with a carbon number of not more than 3, and may optionally be a methanol solution or an ethanol solution. In one embodiment, during the rough extraction step, the tuber or rhizome of Curculigo orchioides is crushed at no higher than room temperature (for example, 10°C to 40°C). Then, the crushed curculio tubers or rhizomes are added to a lower alcohol solution for extraction, and then filtered one or several times to remove residues using gauze, filter paper, centrifugation or other conventional methods to obtain filtrate. In this embodiment, the weight-to-volume ratio (g:mL) of the tuber to the lower alcohol solution is 1:500 to 1:1000.

接著,可選擇性進行脫水步驟,例如減壓濃縮法、冷凍乾燥法等習知方式,去除濾液的低級醇溶液,以獲得粗萃物。在一實施例中,脫水步驟可使用習知方法,例如真空乾燥法、真空冷凍乾燥法、減壓濃縮法等,本發明不限於此處所舉。 Then, a dehydration step can be optionally performed, such as a vacuum concentration method, a freeze-drying method, and other conventional methods to remove the lower alcohol solution of the filtrate to obtain a crude extract. In an embodiment, the dehydration step may use a conventional method, such as a vacuum drying method, a vacuum freeze drying method, a reduced pressure concentration method, etc., and the present invention is not limited to the examples herein.

在一實施例中,利用正己烷(n-Hexane)與水對於上述製得之粗萃物進行分配萃取步驟,以獲得正己烷萃取層及水萃取層。將獲得的正己烷萃取層進行脫水步驟以去除多餘的水份,而獲得正己烷萃取物。 In one embodiment, n-Hexane and water are used to perform a partition extraction step on the crude extract prepared above to obtain a n-Hexane extraction layer and a water extraction layer. The obtained n-hexane extract layer is subjected to a dehydration step to remove excess water to obtain a n-hexane extract.

然後,利用乙酸乙酯(Ethyl acetate)對於上述製得之水萃取層進行分配萃取步驟,以獲得乙酸乙酯萃取層。將獲得的乙酸乙酯萃取層進行脫水步驟以去除多餘的水份,而獲得乙酸乙酯萃取物。 Then, using ethyl acetate (Ethyl acetate) to perform a partition extraction step on the water extraction layer prepared above to obtain an ethyl acetate extraction layer. The obtained ethyl acetate extract layer is subjected to a dehydration step to remove excess water to obtain an ethyl acetate extract.

之後,利用正丁醇(n-Butanol)對於上述製得之水萃取層進行分配萃取步驟,以獲得正丁醇萃取層。將獲得的正丁醇萃取層進行脫水步驟以去除多餘的水份,而獲得正丁醇萃取物。 After that, n-Butanol is used to perform a partition extraction step on the water extraction layer prepared above to obtain an n-Butanol extraction layer. The obtained n-butanol extract layer is subjected to a dehydration step to remove excess water to obtain an n-butanol extract.

上述仙茅萃取物可選擇性地包含粗萃物、正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物之任一種或其任意組合。經實驗證實,上述仙茅萃取物具有皮膚美白及保護DNA的活性,可作為有效成份應用於各種組成物中。在一些實施例中,前述之組成物可例如化妝品組成物或醫藥組成物等。此處所稱化妝品組成物係將仙茅萃取物與化妝品或皮膚病學上可接受的載體或介質所混合,而呈現適用於局部應用的形式。前述之「化妝品或皮膚病學上可接受」表示其與皮膚或人類皮膚附屬物接觸,而不會構成毒性、不耐性、不穩定性、過敏反應等風險之適用於使用者的介質。具體來說,化妝品組成物可用於清潔、保護、保養、美妝皮膚之產品,例如洗面乳、乳液、面膜、化妝品等。 The curculus extract may optionally include any one or any combination of crude extract, n-hexane extract, ethyl acetate extract, and n-butanol extract. Experiments have confirmed that the above Curculigo extracts have skin whitening and DNA protection activities, and can be used as effective ingredients in various compositions. In some embodiments, the aforementioned composition may be, for example, a cosmetic composition or a pharmaceutical composition. The cosmetic composition referred to herein is a mixture of Curculio vulgaris extract with a cosmetically or dermatologically acceptable carrier or medium, and presents a form suitable for topical application. The aforementioned "cosmetic or dermatologically acceptable" means that it is in contact with the skin or human skin appendages, and does not pose a risk of toxicity, intolerance, instability, allergic reactions and other risks suitable for users. Specifically, the cosmetic composition can be used in products for cleaning, protecting, maintaining, and beautifying the skin, such as facial cleansers, lotions, facial masks, cosmetics, and the like.

而此處所稱醫藥組成物係指將仙茅萃取物作為活性成分,與藥學上可接受的載體混合而成,利用所屬領域具有通常知識者已知的技術,配製成用於局部或口服給藥的適合劑量形式。藥學上可接受的載體可包含下列一或多種的製劑:溶劑、乳化劑、懸浮劑、分解劑、結合劑、賦形劑、安定劑、螫合劑、稀釋劑、膠凝劑、防腐劑、潤滑劑、吸收延緩劑、脂質體等。 The medical composition referred to here refers to the curculus extract as the active ingredient, mixed with a pharmaceutically acceptable carrier, and formulated for topical or oral administration using techniques known to those with ordinary knowledge in the field. Suitable dosage form of the medicine. The pharmaceutically acceptable carrier may contain one or more of the following preparations: solvents, emulsifiers, suspending agents, decomposers, binders, excipients, stabilizers, chelating agents, diluents, gelling agents, preservatives, lubricants Agents, absorption delay agents, liposomes, etc.

在應用於美白活性的組成物時,此組成物可包含有效劑量25μg/mL至50μg/mL的仙茅萃取物。 When applied to a whitening active composition, the composition may contain an effective dose of curculus extract at 25 μg/mL to 50 μg/mL.

在應用於具有保護DNA活性的組成物時,此組成物包含有效劑量100μg/mL至500μg/mL的仙茅萃取物,以有效保護DNA免於受損。 When applied to a composition with DNA-protecting activity, the composition contains an effective dose of curculio extract at a dose of 100 μg/mL to 500 μg/mL to effectively protect DNA from damage.

補充說明的是,上述DNA受損的原因並無特別的限制,可以是來自紫外線(ultraviolet;UV)或反應性含氧物種(reactive oxygen species;ROS)所造成之損害。前述的紫外線可包括但不限於紫外線A(UVA)、紫外線B(UVB)、紫外線C(UVC)及/或上述之任意組合。前述的反應性含氧物種可包括但不限於超氧化物(superoxide;O2 -)、羥基自由基(hydroxy radical;‧OH)、過氧化物自由基(peroxide radical;ROO‧)或過氧化氫(H2O2)等。 It is supplemented that there is no particular limitation on the cause of the aforementioned DNA damage, and it can be damage caused by ultraviolet (ultraviolet; UV) or reactive oxygen species (ROS). The aforementioned ultraviolet rays may include, but are not limited to, ultraviolet A (UVA), ultraviolet B (UVB), ultraviolet C (UVC) and/or any combination of the foregoing. The reactive oxygen-containing species may include, but are not limited to superoxide (superoxide; O 2 -), hydroxyl radical (hydroxy radical; ‧OH), peroxide radical (peroxide radical; ROO‧) or hydrogen peroxide (H 2 O 2 ) and so on.

以下利用數個實施例說明本發明之應用,然其並非用以限定本發明,本發明所屬技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可做各種之更動與潤飾。 The following uses several embodiments to illustrate the application of the present invention, but they are not intended to limit the present invention. Those with ordinary knowledge in the technical field to which the present invention belongs can make various modifications and changes without departing from the spirit and scope of the present invention. Retouch.

實施例一:仙茅萃取物之總酚量及總黃酮量的測定Example 1: Determination of the total phenol content and total flavonoid content of Curculio vulgaris extract

首先,於不高於室溫(例如10℃至40℃)下粉碎的仙茅根莖。接著,將粉碎的仙茅根莖加入乙醇溶液。然後,使用紗布、濾紙、離心或其他習知方式過濾一次或數次以去除殘渣,再利用減壓濃縮法進行脫水步驟去除乙醇溶液,而獲得粗萃物。 First, the rhizomes of Curculio vulgaris pulverized at no higher than room temperature (for example, 10°C to 40°C). Next, the crushed Curculio rhizome was added to the ethanol solution. Then, use gauze, filter paper, centrifugation or other conventional methods to filter once or several times to remove the residue, and then use a vacuum concentration method to perform a dehydration step to remove the ethanol solution to obtain a crude extract.

接下來,利用正己烷與水對粗萃物進行分配萃取步驟,以獲得正己烷萃取層及水萃取層。再利用乙酸乙酯對水萃取層進行分配萃取步驟,以獲得乙酸乙酯萃取層。利用正丁醇對於水萃取層進行分配萃取步驟,以獲得正丁醇萃取層。 Next, the crude extract is partitioned and extracted using n-hexane and water to obtain a n-hexane extraction layer and a water extraction layer. The water extraction layer is then subjected to a partition extraction step with ethyl acetate to obtain an ethyl acetate extraction layer. Using n-butanol to perform a partitioning extraction step on the water extraction layer to obtain a n-butanol extraction layer.

將前述獲得的正己烷萃取層、乙酸乙酯萃取層及正丁醇萃取層,利用減壓濃縮法進行脫水步驟,以去除多餘的水份,而獲得正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物。此處所製得的粗萃物、正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物之任一種或其任意組合即為本發明之仙茅萃取物。 The n-hexane extraction layer, the ethyl acetate extraction layer, and the n-butanol extraction layer obtained above are subjected to a dehydration step using a reduced pressure concentration method to remove excess water to obtain a n-hexane extract, an ethyl acetate extract, and N-Butanol extract. Any one or any combination of the crude extract, n-hexane extract, ethyl acetate extract, and n-butanol extract prepared here is the Curculigo extract of the present invention.

接著,測定仙茅萃取物之總酚量(total phenolic contents;TPC)及總黃酮量(total flavonoids content;TFC)。分別取1μL、1000μg/ml之粗萃物、正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物,加入250μL的十倍稀釋之福林酚試劑(Folin-Ciocalteu’s phenol reagent),經振盪混合後,靜置5分鐘,再加入200μL 7.5%的碳酸鈉(Na2CO3)溶液及500μL的去離子水(ddH2O),於室溫避光1小時後,以分光光度計(例如SynergyTM 2多功能微量盤測讀機(Multi-Mode Microplate Reader;BioTek,U.S.A.)測波長760nm吸光值。對照沒食子酸(Galic acid)標準品製作校正曲線,換算每克仙茅萃取物中所含的沒食子酸當量(gallic acid equivalents),以計算仙茅萃取物的總酚量。 Next, the total phenolic contents (TPC) and total flavonoids content (TFC) of the curculio extract were determined. Take 1μL, 1000μg/ml crude extract, n-hexane extract, ethyl acetate extract and n-butanol extract respectively, add 250μL ten-fold diluted Folin-Ciocalteu's phenol reagent, and shake After mixing, let stand for 5 minutes, then add 200μL of 7.5% sodium carbonate (Na 2 CO 3 ) solution and 500μL of deionized water (ddH 2 O), protect from light at room temperature for 1 hour, and use a spectrophotometer (e.g. Synergy TM 2 Multi-Mode Microplate Reader (BioTek, USA) measures the absorbance at a wavelength of 760nm. Make a calibration curve against the standard galic acid, and convert it into every gram of Curculio extract Contains gallic acid equivalents (gallic acid equivalents), to calculate the total phenolic content of Curculio vulgaris extract.

另分別取1μL、1000μg/ml之粗萃物、正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物,加入490μL去離子水及3μL 5%亞硝酸鈉(NaNO2)反應6分鐘後,再加入30μL 10%的氯化鋁(AlCl3)反應6分鐘後,加入400μL 4%的氫氧化鈉(NaOH)及40μL的去離子水振盪混合均勻後,靜置15分鐘,以分光光度計測波長510nm吸光值。對照芸香苷(Rutin)標準品製作校正曲線。換算每克仙茅萃取物中所含的芸香苷當量(rutin equivalents),以計算仙茅萃取物的類黃酮化合物之總黃酮量。 Separately take 1μL, 1000μg/ml crude extract, n-hexane extract, ethyl acetate extract and n-butanol extract, add 490μL deionized water and 3μL 5% sodium nitrite (NaNO 2 ) to react for 6 minutes , Then add 30μL of 10% aluminum chloride (AlCl 3 ) to react for 6 minutes, add 400μL of 4% sodium hydroxide (NaOH) and 40μL of deionized water, shake and mix uniformly, let stand for 15 minutes, measure with spectrophotometer Absorbance at 510nm wavelength. Make a calibration curve against Rutin standards. Calculate the total flavonoids of the flavonoids in the curculus extract by converting the rutin equivalents contained in each gram of the curculus extract.

結果顯示,乙醇萃取物的總酚量相當於18.8mg/g之沒食子酸當量,而其總黃酮量相當於64.3mg/g之芸香苷當量。正己烷萃取物的總酚量相當於3.1mg/g之沒食子酸當量,而其總黃酮量相當於107.2mg/g之芸香苷當量。乙酸乙酯萃取物的總酚量相當於32.8mg/g之沒食子酸當量,而其總黃酮量相當於232.6mg/g之芸香苷當量。正丁醇萃取物的總酚量相當於25.5mg/g之沒食子酸當量,而其總黃酮量相當於151.5mg/g之芸香苷當量。 The results showed that the total phenol content of the ethanol extract was equivalent to 18.8 mg/g gallic acid equivalent, and the total flavonoid content was equivalent to 64.3 mg/g rutin equivalent. The total phenol content of the n-hexane extract is equivalent to 3.1 mg/g gallic acid equivalent, and the total flavonoid content is equivalent to 107.2 mg/g rutin equivalent. The total phenol content of the ethyl acetate extract is equivalent to 32.8 mg/g gallic acid equivalent, and the total flavonoid content is equivalent to 232.6 mg/g rutin equivalent. The total phenol content of the n-butanol extract is equivalent to 25.5mg/g of gallic acid equivalent, and the total flavonoid content is equivalent to 151.5mg/g of rutin equivalent.

實施例二:仙茅萃取物於細胞內抑制黑色素生成的評估Example 2: Evaluation of Curculio extract inhibiting melanin production in cells

細胞之黑色素(melanogenesis)主要透過α-黑色素細胞刺激素(α-melanocyte-stimulating hormone;α-MSH)活化酪胺酸酶(tyrosinase)反應生成。反應途徑為酪胺酸(tyrosine)經酪胺酸酶催化形成多巴二羥苯丙氨酸(dihydroxyphenylalanine;DOPA),DOPA 再度經酪胺酸酶催化則形成多巴醌(DOPAquinone),進而引起黑色素的合成。藉由抑制酪胺酸酶的活性,可減少黑色素的合成。本實施例利用黑色素癌細胞作為分析模式,分別評估仙茅萃取物抑制細胞內之酪胺酸酶活性及黑色素含量的效果。 The melanogenesis of cells is mainly produced through the activation of tyrosinase by α-melanocyte-stimulating hormone (α-MSH). The reaction pathway is tyrosine catalyzed by tyrosinase to form dopa dihydroxyphenylalanine (DOPA), DOPA Once again catalyzed by tyrosinase, DOPAquinone is formed, which in turn leads to the synthesis of melanin. By inhibiting the activity of tyrosinase, the synthesis of melanin can be reduced. In this example, melanoma cancer cells were used as the analysis mode to evaluate the effects of Curculio vulgaris extract on inhibiting tyrosinase activity and melanin content in the cells.

1. 仙茅萃取物於細胞內抑制酪胺酸酶活性1. Curculigo extract inhibits tyrosinase activity in cells

此實施例係利用蘑菇酪胺酸酶作為細胞外(in vitro)模式,評估仙茅萃取物抑制黑色素癌細胞B16F10(寄存編號:BCRC 60031)的細胞內酪胺酸酶活性之效果。首先,將黑色素癌細胞B16F10細胞培養於96孔細胞培養盤中,在37ºC、5% CO2下培養至少24小時。接著,將細胞分成控制組(每孔2μL的水)、α-MSH處理組(每孔0.1μM的α-MSH)、各處理組〔每孔0.1μM的α-MSH及2μL實施例一之不同仙茅萃取物(25μg/mL至50μg/mL)〕或熊果素處理組〔每孔0.1μM的α-MSH及2μL之50μg/mL熊果素)〕,處理72小時。然後,每孔加入18μL之二甲亞碸(dimethyl sulfoxide;DMSO)混合均勻,於室溫反應10分鐘,再加入155μL 2.5mM之L-DOPA,室溫反應20分鐘。之後,利用市售多功能微量盤測讀機(例如SynergyTM2 Multi-Detection Microplate Reader,BioTek Instruments,Inc.,U.S.A.),根據製造商(例如CellTiter 96 AQ,Promega,Madison.WI,U.S.A.)提供之使用手冊,測量各孔細胞於波長492nm的吸光值 (OD492nm)。以控制組之OD492nm作為100%,換算出各組細胞內的酪胺酸酶活性(%),其結果如圖1A所示。 In this example, mushroom tyrosinase was used as an in vitro model to evaluate the effect of Curculio vulgaris extract on inhibiting the intracellular tyrosinase activity of melanoma cancer cells B16F10 (accession number: BCRC 60031). First, culture the B16F10 melanoma cells in a 96-well cell culture dish at 37ºC and 5% CO 2 for at least 24 hours. Next, divide the cells into a control group (2μL of water per well), a-MSH treatment group (0.1μM of α-MSH per well), and each treatment group (0.1μM of α-MSH per well and 2μL of the difference in Example 1 Curculigo extract (25μg/mL to 50μg/mL)] or arbutin treatment group (0.1μM α-MSH and 2μL of 50μg/mL arbutin per well), treated for 72 hours. Then, add 18 μL of dimethyl sulfoxide (DMSO) to each well, mix well, and react at room temperature for 10 minutes, then add 155 μL of 2.5 mM L- DOPA, and react at room temperature for 20 minutes. After that, use a commercially available multi-function microplate reader (such as Synergy TM 2 Multi-Detection Microplate Reader, BioTek Instruments, Inc., USA), according to the manufacturer (such as CellTiter 96 AQ, Promega, Madison.WI, USA) provided Measure the absorbance value (OD 492nm ) of cells in each well at a wavelength of 492nm. Taking the OD 492nm of the control group as 100%, the tyrosinase activity (%) in the cells of each group was converted, and the result is shown in Figure 1A.

請參閱圖1A,其係繪示根據本發明一實施例之仙茅萃取物對於細胞內酪胺酸酶活性之直條圖。其中,X軸由左至右分別代表控制組(未經處理之B16F10細胞)、α-MSH組(添加α-MSH之B16F10細胞)、各處理組〔添加α-MSH與粗萃物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞;添加α-MSH與正己烷萃取物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞;添加α-MSH與乙酸乙酯萃取物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞;添加α-MSH與正丁醇萃取物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞〕及熊果素組〔添加α-MSH與熊果素(Arbutin)(50μg/mL)之B16F10細胞〕。Y軸為細胞內酪胺酸酶的活性(%)。 Please refer to FIG. 1A, which is a bar graph showing the activity of Curculigo vulgaris extract on intracellular tyrosinase activity according to an embodiment of the present invention. Among them, the X axis represents the control group (untreated B16F10 cells), the α-MSH group (the B16F10 cells with α-MSH), and each treatment group (with α-MSH and crude extract (concentrations respectively) from left to right. B16F10 cells with 25μg/mL and 50μg/mL); B16F10 cells with α-MSH and n-hexane extracts (concentrations of 25μg/mL and 50μg/mL respectively); α-MSH and ethyl acetate extracts (concentrations) 25μg/mL and 50μg/mL) B16F10 cells; B16F10 cells supplemented with α-MSH and n-butanol extract (concentrations of 25μg/mL and 50μg/mL, respectively) and the arbutin group (with α-MSH and arbutin) (Arbutin) (50μg/mL) B16F10 cells]. The Y axis is the activity (%) of tyrosinase in the cell.

由圖1A之結果顯示,相較於α-MSH組,在添加粗萃物、正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物後,B16F10細胞內酪胺酸酶活性均有下降。其中以正丁醇萃取物對於酪胺酸酶的抑制活性較佳,正己烷萃取物次之,然後為乙酸乙酯萃取物及粗萃物。因此,上述結果證實仙茅萃取物具有抑制酪胺酸酶之活性。 The results in Figure 1A show that compared with the α-MSH group, after adding crude extract, n-hexane extract, ethyl acetate extract, and n-butanol extract, the tyrosinase activity in B16F10 cells decreased . Among them, the n-butanol extract has the best inhibitory activity on tyrosinase, followed by the n-hexane extract, followed by the ethyl acetate extract and the crude extract. Therefore, the above results confirm that Curculio vulgaris extract has the activity of inhibiting tyrosinase.

2. 仙茅萃取物降低細胞內黑色素含量之評估2. Evaluation of Curculigo extract reducing the melanin content in cells

此實施例係利用B16F10細胞作為細胞模式,評估仙茅萃取物抑制細胞內黑色素含量之效果。首先,將B16F10細胞(1×105細胞/mL,每孔1mL)加入24孔細胞培養盤中,置於37℃、5% CO2培養箱培養至少24小時。上述細胞分成控制組(每孔1μL的水)、α-MSH處理組(每孔0.1μM的α-MSH,每孔100μL)、各處理組〔0.1μM的α-MSH及1μL的實施例一之仙茅萃取物(25μg/mL至50μg/mL)〕或熊果素處理組〔每孔0.1μM的α-MSH及2μL之50μg/mL熊果素)〕,於37℃,5% CO2中培養72小時。之後,移除培養液,於每孔加入300μL之1當量濃度(N)的氫氧化鈉(NaOH)溶解細胞後,利用前述市售多功能微量盤測讀機測量各孔細胞溶解液於波長405nm的吸光值(OD405nm)。以未經處理之B16F10細胞(控制組)之黑色素含量作為100%,換算出各組細胞內的黑色素含量(%),其結果如圖1B所示。 In this example, B16F10 cells were used as the cell model to evaluate the effect of Curculio vulgaris extract on inhibiting melanin content in cells. First, add B16F10 cells (1×10 5 cells/mL, 1 mL per well) to a 24-well cell culture dish and place them in a 37°C, 5% CO 2 incubator for at least 24 hours. The above-mentioned cells are divided into control group (1μL water per well), α-MSH treatment group (0.1μM α-MSH per well, 100μL per well), and each treatment group (0.1μM α-MSH and 1μL of Example 1) Curculigo extract (25μg/mL to 50μg/mL)] or arbutin treatment group (0.1μM α-MSH per well and 2μL of 50μg/mL arbutin)], cultured at 37°C, 5% CO 2 for 72 hours. After that, remove the culture medium, add 300 μL of 1 equivalent concentration (N) of sodium hydroxide (NaOH) to each well to dissolve the cells, and measure the cell lysate in each well at a wavelength of 405nm using the aforementioned commercially available multi-function microplate reader. The absorbance value (OD 405nm ). Taking the melanin content of the untreated B16F10 cells (control group) as 100%, the melanin content (%) in the cells of each group was converted, and the result is shown in Figure 1B.

請參閱圖1B,其係繪示根據本發明一實施例之仙茅萃取物降低細胞內黑色素含量之直條圖。其中,X軸由左至右分別代表控制組(未經處理之B16F10細胞)、各處理組〔添加α-MSH之B16F10細胞(α-MSH組);添加α-MSH與粗萃物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞;添加α-MSH與正己烷萃取物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞;添加α-MSH與乙酸乙酯萃取物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞;添加α-MSH與正丁醇萃取物(濃度分別為25μg/mL與50μg/mL)的B16F10細胞〕及熊果素組〔添加α-MSH與熊果素(50μg/mL)之B16F10細胞〕。Y軸為細胞內黑色素含量(%)。 Please refer to FIG. 1B, which is a bar graph showing the reduction of melanin content in cells by Curculio vulgaris extract according to an embodiment of the present invention. Among them, the X axis represents the control group (untreated B16F10 cells) and each treatment group (the B16F10 cells with α-MSH (α-MSH group) from left to right; α-MSH and crude extracts are added (concentrations respectively) B16F10 cells with 25μg/mL and 50μg/mL); B16F10 cells with α-MSH and n-hexane extracts (concentrations of 25μg/mL and 50μg/mL respectively); α-MSH and ethyl acetate extracts (concentrations) 25μg/mL and 50μg/mL) B16F10 cells; B16F10 cells supplemented with α-MSH and n-butanol extract (concentrations of 25μg/mL and 50μg/mL, respectively) and the arbutin group (with α-MSH and arbutin) (50μg/mL) of B16F10 cells]. The Y-axis is the intracellular melanin content (%).

由圖1B之結果顯示,添加仙茅萃取物(粗萃物、正己烷萃取物、乙酸乙酯萃取物或正丁醇萃取物)的B16F10細胞,其細胞內黑色素含量均較添加熊果素之B16F10細胞的細胞內黑色素含量低。其中以粗萃物對於降低細胞內黑色素含量的效果較佳,正己烷萃取物及正丁醇萃取物次之,然後為乙酸乙酯萃取物。因此,上述結果證實仙茅萃取物具有降低細胞內黑色素含量之效果。 The results in Figure 1B show that B16F10 cells with Curculigo extract (crude extract, n-hexane extract, ethyl acetate extract or n-butanol extract) have a higher intracellular melanin content than B16F10 cells added with arbutin The melanin content in the cells is low. Among them, the crude extract has the better effect on reducing the melanin content in the cells, followed by the n-hexane extract and the n-butanol extract, and then the ethyl acetate extract. Therefore, the above results confirm that Curculio vulgaris extract has the effect of reducing the melanin content in cells.

實施例三:仙茅萃取物保護DNA效果的評估Example 3: Evaluation of the effect of Curculio vulgaris extract on DNA protection

過氧化氫(H2O2)經代謝及/或UVB照射後形成羥基自由基,羥基自由基攻擊DNA並使DNA結構受損。本實施例利用過氧化氫及UVB照射,模擬自由基對超螺旋型(supercoiled;SC)的pUC119質體DNA之傷害,使超螺旋型的pUC119質體DNA受損而形成開環型(open circular;OC)或線型(linear;LC)的結構,由超螺旋型DNA及開環型DNA的比例評估仙茅萃取物保護DNA的效果。 Hydrogen peroxide (H 2 O 2 ) is metabolized and/or UVB irradiated to form hydroxyl free radicals, which attack DNA and damage the DNA structure. In this example, hydrogen peroxide and UVB irradiation were used to simulate the damage of free radicals to the supercoiled (SC) pUC119 plastid DNA, and the supercoiled pUC119 pUC119 plastid DNA was damaged to form an open circular type (open circular). ; OC) or linear (linear; LC) structure. The effect of curculus extract on DNA protection is evaluated by the ratio of supercoiled DNA and open-circular DNA.

此實施例先將25μg、0.5μg/μL的pUC119質體DNA(TaKaRa,Japan)使用PBS稀釋,且pUC119質體DNA與PBS之體積比為1:9。取2μL的稀釋後之pUC119質體DNA加入4μL的PBS,不添加(控制組;氧化及UVB傷害組)或添加2μL不同濃度(100μg/mL與500μg/mL) 的實施例一之仙茅萃取物,並不施以(控制組)或施以2μL、0.1mM之過氧化氫與2μL、0.5mM硫酸亞鐵(FeSO4),不照射(控制組)或照射劑量20mJ/cm2之UVB,並在37℃下等待1小時後。利用濃度0.8%之瓊脂凝膠進行電泳。使用影像擷取分析系統拍下電泳膠片,其結果如圖2A所示。圖2A經影像分析軟體計算出各色帶的螢光強度後,以控制組的超螺旋型DNA及開環型DNA之螢光強度分別作為1.0,換算各泳道的超螺旋型DNA或開環型DNA之相對螢光比,其結果如圖2B所示。若超螺旋型DNA或開環型DNA的螢光比值越高,代表仙茅萃取物保護DNA的能力越佳。 In this example, 25 μg, 0.5 μg/μL of pUC119 plastid DNA (TaKaRa, Japan) was diluted with PBS, and the volume ratio of pUC119 plastid DNA to PBS was 1:9. Take 2μL of the diluted pUC119 plastid DNA and add 4μL of PBS, without adding (control group; oxidation and UVB injury group) or adding 2μL of the Curculio vulgaris extract of Example 1 with different concentrations (100μg/mL and 500μg/mL) , Do not apply (control group) or apply 2μL, 0.1mM hydrogen peroxide and 2μL, 0.5mM ferrous sulfate (FeSO 4 ), do not irradiate (control group) or irradiation dose of 20mJ/cm 2 UVB, and After waiting for 1 hour at 37°C. Use 0.8% agar gel for electrophoresis. The electrophoresis film was photographed using the image capture analysis system, and the result is shown in Figure 2A. Figure 2A After the fluorescence intensity of each color band is calculated by the image analysis software, the fluorescence intensity of the supercoiled DNA and the open circle DNA of the control group are respectively set as 1.0, and the supercoiled DNA or open circle DNA of each lane is converted The relative fluorescence ratio, the result is shown in Figure 2B. The higher the fluorescence ratio of supercoiled DNA or open-circle DNA, the better the ability of Curculio extract to protect DNA.

請參閱圖2A,其為顯示在過氧化氫(H2O2)及UVB的處理下,仙茅萃取物保護DNA之核酸電泳圖。其中,電泳泳道(lane)由左至右為控制組(未經處理之pUC119質體DNA)、氧化及UVB傷害組(同時施予過氧化氫、硫酸亞鐵及UVB之pUC119質體DNA)以及各處理組〔同時施予過氧化氫、硫酸亞鐵、UVB及粗萃物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA;同時施予過氧化氫、硫酸亞鐵、UVB及正己烷萃取物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA;同時施予過氧化氫、硫酸亞鐵、UVB及乙酸乙酯萃取物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA;與同時施予過氧化氫、硫酸亞鐵、UVB及正丁醇萃取物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA〕。以未經處理之pUC119質體DNA(控制組)之超螺旋型DNA及開環 型DNA的螢光強度作為1.0,換算出各泳道之超螺旋型DNA及開環型DNA相對的螢光強度比,其結果如圖2B所示。 Please refer to FIG. 2A, which is a nucleic acid electrophoresis diagram showing the protection of DNA from Curculio vulgaris extract under the treatment of hydrogen peroxide (H 2 O 2) and UVB. Among them, the electrophoresis lanes (lane) from left to right are the control group (untreated pUC119 plastid DNA), the oxidation and UVB damage group (the pUC119 pUC119 plastid DNA was simultaneously administered with hydrogen peroxide, ferrous sulfate and UVB) and Each treatment group [simultaneously administered hydrogen peroxide, ferrous sulfate, UVB, and crude extracts (concentrations of 100μg/mL and 500μg/mL) pUC119 plastid DNA; simultaneously administered hydrogen peroxide, ferrous sulfate, UVB And n-hexane extracts (concentrations of 100μg/mL and 500μg/mL respectively) pUC119 plastid DNA; simultaneously administered with hydrogen peroxide, ferrous sulfate, UVB and ethyl acetate extracts (concentrations of 100μg/mL and 500μg, respectively) /mL) pUC119 plastid DNA; and simultaneously administered with hydrogen peroxide, ferrous sulfate, UVB and n-butanol extracts (concentrations of 100μg/mL and 500μg/mL, respectively) pUC119 pUC119 plastid DNA]. Taking the fluorescence intensity of the supercoiled DNA and the open-circle DNA of the untreated pUC119 plastid DNA (control group) as 1.0, calculate the relative fluorescence intensity ratio of the supercoiled DNA and open-circle DNA in each lane , And the result is shown in Figure 2B.

請參閱圖2B,其係繪示圖2A各組之超螺旋型DNA及開環型DNA的螢光強度比之直條圖。其中,X軸由左至右代表未經處理之pUC119質體DNA(控制組);同時施予過氧化氫、硫酸亞鐵及UVB之pUC119質體DNA(氧化及UVB傷害組);同時施予過氧化氫、硫酸亞鐵、UVB及粗萃物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA;同時施予過氧化氫、硫酸亞鐵、UVB及正己烷萃取物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA;同時施予過氧化氫、硫酸亞鐵、UVB及乙酸乙酯萃取物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA;與同時施予過氧化氫、硫酸亞鐵、UVB及正丁醇萃取物(濃度分別為100μg/mL及500μg/mL)之pUC119質體DNA。Y軸代表超螺旋型(SC)DNA與開環型(OC)DNA的螢光強度比。 Please refer to FIG. 2B, which is a bar graph showing the fluorescence intensity ratio of the supercoiled DNA and the open-circular DNA of each group in FIG. 2A. Among them, the X axis from left to right represents untreated pUC119 plastid DNA (control group); pUC119 pUC119 plastid DNA (oxidation and UVB damage group) administered simultaneously with hydrogen peroxide, ferrous sulfate and UVB; simultaneously administered Hydrogen peroxide, ferrous sulfate, UVB and crude extracts (concentrations of 100μg/mL and 500μg/mL, respectively) pUC119 plastid DNA; simultaneously administered with hydrogen peroxide, ferrous sulfate, UVB and n-hexane extract (concentration 100μg/mL and 500μg/mL) pUC119 plastid DNA; simultaneously administered with hydrogen peroxide, ferrous sulfate, UVB and ethyl acetate extract (concentrations of 100μg/mL and 500μg/mL respectively) pUC119 pUC119 plastid DNA; pUC119 pUC119 plastid DNA simultaneously administered with hydrogen peroxide, ferrous sulfate, UVB and n-butanol extracts (concentrations of 100μg/mL and 500μg/mL, respectively). The Y-axis represents the fluorescence intensity ratio of supercoiled (SC) DNA to open circle (OC) DNA.

由圖2A及圖2B之結果顯示,正己烷萃取物及乙酸乙酯萃取物使pUC119質體DNA維持在超螺旋型的比例較高,粗萃物次之,然後為正丁醇萃取物。且添加正己烷萃取物、乙酸乙酯萃取物、500μg/mL的粗萃物及500μg/mL的正丁醇萃取物之pUC119質體DNA,其維持在超螺旋型DNA的量均較於氧化及UVB傷害組多。因此,上述 結果證實,仙茅萃取物具有保護DNA免於氧化及UVB傷害的活性。 The results of Fig. 2A and Fig. 2B show that the n-hexane extract and ethyl acetate extract maintain a higher proportion of pUC119 plastid DNA in the supercoiled form, followed by the crude extract, and then the n-butanol extract. And adding n-hexane extract, ethyl acetate extract, 500μg/mL crude extract and 500μg/mL n-butanol extract of pUC119 plastid DNA, which maintains the amount of supercoiled DNA compared to oxidation and There are many UVB damage groups. Therefore, the above The results confirmed that Curculigo extract has the activity of protecting DNA from oxidation and UVB damage.

實施例四:仙茅萃取物之細胞毒性的評估Example 4: Evaluation of the cytotoxicity of Curculio vulgaris extract

此實施例係利用HaCaT細胞或B16F10的細胞,在不添加或添加仙茅萃取物的情況下進行共培養,以評估仙茅萃取物之細胞毒性。 In this example, HaCaT cells or B16F10 cells were used for co-cultivation without addition or addition of curculus extracts to evaluate the cytotoxicity of curculus extracts.

在此實施中,首先將HaCaT細胞或B16F10細胞培養在杜爾貝寇改良伊格培養基(Dulbecco's modified Eagle’s medium;DMEM;GIBCO,Grand Island,NY)、10%胎牛血清(Hazelton Product,Denver,PA,USA)與1%盤尼西林-鏈黴素(penicillin-streptomycin)中,在5% CO2、37℃培養箱內培養。再以1×104細胞/孔之細胞濃度將HaCaT細胞或B16F10細胞接種於96孔細胞培養盤中,以在37℃、5% CO2培養箱中培養至少24小時。接著,於96孔細胞培養盤之每孔細胞中,不添加(控制組)或添加不同濃度(25μg/mL至100μg/mL)的實施例一之仙茅萃取物之新鮮培養液,共培養24小時。然後,利用溴化3-(4,5-二甲基-2-噻唑基)-2,5-二苯基四氮唑[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;MTT]法評估HaCaT細胞或B16F10細胞的細胞存活率(cell viability)。 In this implementation, first, HaCaT cells or B16F10 cells were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, NY), 10% fetal bovine serum (Hazelton Product, Denver, PA). , USA) and 1% penicillin-streptomycin (penicillin-streptomycin) in 5% CO 2 , 37 ℃ incubator. Then inoculate HaCaT cells or B16F10 cells in a 96-well cell culture dish at a cell concentration of 1×10 4 cells/well, and culture them in a 37°C, 5% CO 2 incubator for at least 24 hours. Then, in each well of the 96-well cell culture plate, without adding (control group) or adding different concentrations (25μg/mL to 100μg/mL) of the fresh culture solution of Curculio vulgaris extract of Example 1 for a total of 24 Hour. Then, use bromide 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium [3-(4,5-dimethylthiazol-2-yl)-2,5 -diphenyltetrazolium bromide; MTT] method to evaluate the cell viability of HaCaT cells or B16F10 cells.

首先,於96孔細胞培養盤每孔細胞中加入10μL、5mg/mL之MTT,於37℃且5% CO2下培養4小時後,移除上清液,再加入100μL之DMSO溶解的MTT甲臢(MTT formazan),震盪5分鐘後,測量其於波長570nm的吸光值(OD570nm),以計算細胞存活率。以未添加仙茅萃取物之HaCaT細胞或B16F10細胞(控制組)的細胞存活率作為100%,計算細胞在不同濃度之仙茅萃取物下的存活率,結果分別如圖3A(HaCaT細胞)及圖3B(B16F10細胞)所示。如細胞存活率越高,代表仙茅萃取物對於細胞的毒性越低。 First, add 10 μL of 5 mg/mL MTT to each well of a 96-well cell culture plate . After incubating for 4 hours at 37°C and 5% CO 2 , remove the supernatant, and then add 100 μL of DMSO dissolved MTT. After shaking for 5 minutes, measure the absorbance (OD 570nm ) at a wavelength of 570nm to calculate the cell viability. Taking the cell survival rate of HaCaT cells or B16F10 cells (control group) without addition of Curculigo extract as 100%, calculate the survival rate of the cells under different concentrations of Curculia extract. The results are shown in Figure 3A (HaCaT cells) and Figure 3B (B16F10 cells). For example, the higher the cell survival rate, the lower the toxicity of Curculio curculio extract to cells.

請參閱圖3A,係繪示根據本發明一實施例之仙茅萃取物與HaCaT細胞共培養的細胞存活率之直條圖。其中,X軸由左至右分別代表粗萃物(濃度分別為25μg/mL、50μg/mL、100μg/mL)、正己烷萃取物(濃度分別為25μg/mL、50μg/mL、100μg/mL)、乙酸乙酯萃取物(濃度分別為25μg/mL、50μg/mL、100μg/mL)及正丁醇萃取物(濃度分別為25μg/mL、50μg/mL、100μg/mL)。Y軸代表HaCaT細胞之細胞存活率(%)。 Please refer to FIG. 3A, which is a bar graph showing the survival rate of the cells co-cultured with Curculio vulgaris extract and HaCaT cells according to an embodiment of the present invention. Among them, the X axis from left to right represents crude extract (concentrations of 25μg/mL, 50μg/mL, 100μg/mL) and n-hexane extract (concentrations of 25μg/mL, 50μg/mL, 100μg/mL) , Ethyl acetate extract (concentrations of 25μg/mL, 50μg/mL, 100μg/mL) and n-butanol extract (concentrations of 25μg/mL, 50μg/mL, 100μg/mL). The Y axis represents the cell survival rate (%) of HaCaT cells.

由圖3A之結果顯示,HaCaT細胞與仙茅萃取物共培養24小時後,細胞存活率均維持在80%以上,顯示仙茅萃取物對於HaCaT細胞不具細胞毒性。 The results in Fig. 3A show that after 24 hours of co-cultivation of HaCaT cells and Curculio extract, the cell survival rate was maintained at more than 80%, indicating that Curculia extract is not cytotoxic to HaCaT cells.

請參閱圖3B,係繪示根據本發明一實施例之仙茅萃取物與B16F10細胞共培養的細胞存活率之直條圖。其中,X軸由左至右分別代表粗萃物(控制組以及濃度 分別為25μg/mL、50μg/mL、100μg/mL之粗萃物)、正己烷萃取物(控制組以及濃度分別為25μg/mL、50μg/mL、100μg/mL之正己烷萃取物)、乙酸乙酯萃取物(控制組以及濃度分別為25μg/mL、50μg/mL、100μg/mL之乙酸乙酯萃取物)及正丁醇萃取物(控制組以及濃度分別為25μg/mL、50μg/mL、100μg/mL之正丁醇萃取物)。Y軸代表B16F10細胞之細胞存活率(%)。 Please refer to FIG. 3B, which is a bar graph showing the survival rate of cells co-cultured with Curculio vulgaris extract and B16F10 cells according to an embodiment of the present invention. Among them, the X axis from left to right represents the crude extract (control group and concentration 25μg/mL, 50μg/mL, 100μg/mL crude extract), n-hexane extract (control group and n-hexane extract with concentration of 25μg/mL, 50μg/mL, 100μg/mL), ethyl acetate Ester extract (control group and ethyl acetate extract with concentration of 25μg/mL, 50μg/mL, 100μg/mL) and n-butanol extract (control group and concentration of 25μg/mL, 50μg/mL, 100μg, respectively /mL of n-butanol extract). The Y axis represents the cell survival rate (%) of B16F10 cells.

由圖3B之結果顯示,B16F10細胞與仙茅萃取物共培養24小時後,細胞存活率均維持在75%以上,顯示仙茅萃取物對於B16F10細胞不具細胞毒性。 The results in Fig. 3B show that after 24 hours of co-cultivation of B16F10 cells and Curculio extract, the cell survival rate is maintained above 75%, indicating that Curculia extract is not cytotoxic to B16F10 cells.

實施例五:仙茅萃取物對於一氧化氮(NO)自由基清除能力Example 5: Scavenging ability of Curculio vulgaris extract on nitric oxide (NO) free radicals

一氧化氮(NO)自由基於體內分布廣泛,且在多項生理作用、防禦及訊息傳遞上扮演重要的角色。惟由於自由基的活性高且不穩定,過多的自由基會和體內的細胞組織產生氧化反應,將導致細胞組織失去正常功能,甚至破壞DNA。 Nitric oxide (NO) is freely distributed in the body and plays an important role in many physiological functions, defenses and information transmission. However, due to the high activity and instability of free radicals, too many free radicals will produce oxidative reactions with the cells and tissues in the body, which will cause the cells and tissues to lose their normal functions and even damage DNA.

在此實施例中,分別取2μL且不同濃度(25μg/mL至500μg/mL)之實施例一的粗萃物、正己烷萃取物、乙酸乙酯萃取物及正丁醇萃取物,進行一氧化氮自由基清除能力的測定。不添加(控制組)或添加前述不同濃度的仙茅萃取物至96孔微量多孔盤中,再加入10mM的硝普鈉(sodium nitroprusside),置於室溫反應2小時後,加入革 利士試劑(Griess reagent)[含有0.1%萘二胺二鹽酸鹽(naphthylenediamine dihydrochloride;NED)化合物、5%磷酸(H3PO4)及1%苯磺胺(sulfanilamide)]置於室溫反應10分鐘後,於波長546nm測定吸光值(OD546nm)。以未添加仙茅萃取物(控制組)之OD546nm作為100%,換算出一氧化氮自由基之清除率(%)。測得的吸光值越低時,代表仙茅萃取物的抗氧化能力越佳,則一氧化氮自由基之清除率越高。 In this example, take 2 μL and different concentrations (25 μg/mL to 500 μg/mL) of the crude extract, n-hexane extract, ethyl acetate extract, and n-butanol extract of Example 1, and perform monoxide oxidation. Determination of nitrogen radical scavenging ability. Do not add (control group) or add the aforementioned Curculio extracts of different concentrations to a 96-well microporous plate, then add 10 mM sodium nitroprusside (sodium nitroprusside), react at room temperature for 2 hours, then add Cres' reagent (Griess reagent) [Containing 0.1% naphthylenediamine dihydrochloride (NED) compound, 5% phosphoric acid (H 3 PO 4 ) and 1% sulfanilamide] After reacting at room temperature for 10 minutes, The absorbance (OD 546nm ) was measured at a wavelength of 546nm. Take the OD 546nm without addition of Curculigo extract (control group) as 100%, and calculate the nitric oxide free radical scavenging rate (%). The lower the measured absorbance value, the better the antioxidant capacity of Curculigo, and the higher the scavenging rate of nitric oxide free radicals.

請參閱圖4,其係繪示本發明一實施例之仙茅萃取物於體外一氧化氮自由基的清除率之直條圖。在圖4中,X軸由左至右分別代表粗萃物(控制組以及濃度分別為25μg/mL、50μg/mL、100μg/mL、500μg/mL之粗萃物)、正己烷萃取物(控制組以及濃度分別為25μg/mL、50μg/mL、100μg/mL、500μg/mL之正己烷萃取物)、乙酸乙酯萃取物(控制組以及濃度分別為25μg/mL、50μg/mL、100μg/mL、500μg/mL之乙酸乙酯萃取物)及正丁醇萃取物(控制組以及濃度分別為25μg/mL、50μg/mL、100μg/mL、500μg/mL之正丁醇萃取物)以及芸香苷(濃度為50μg/mL及100μg/mL)。Y軸代表一氧化氮自由基之清除率(%)。 Please refer to FIG. 4, which is a bar graph showing the scavenging rate of nitric oxide free radicals in vitro of Curculio vulgaris extract according to an embodiment of the present invention. In Figure 4, the X axis represents crude extracts from left to right (control group and crude extracts with concentrations of 25μg/mL, 50μg/mL, 100μg/mL, 500μg/mL), n-hexane extract (control group) Group and concentration of 25μg/mL, 50μg/mL, 100μg/mL, 500μg/mL n-hexane extract), ethyl acetate extract (control group and concentration were 25μg/mL, 50μg/mL, 100μg/mL, respectively) , 500μg/mL ethyl acetate extract) and n-butanol extract (control group and n-butanol extract with concentrations of 25μg/mL, 50μg/mL, 100μg/mL, 500μg/mL) and rutin ( The concentration is 50μg/mL and 100μg/mL). The Y axis represents the scavenging rate (%) of nitric oxide free radicals.

由圖4之結果顯示,隨著仙茅萃取物之濃度升高,一氧化氮自由基清除能力亦增強。其中以粗萃物對於一氧化氮自由基清除能力較佳,乙酸乙酯萃取物及正丁醇萃取物次之,然後為正己烷萃取物,證實仙茅萃取物具有清除 一氧化氮自由基之效果。 The results in Figure 4 show that as the concentration of Curculigo extract increases, the scavenging ability of nitric oxide radicals also increases. Among them, the crude extract has better scavenging ability for nitric oxide radicals, followed by ethyl acetate extract and n-butanol extract, followed by n-hexane extract, which confirms that Curculigo extract has the ability to remove The effect of nitric oxide free radicals.

綜而言之,由上述數個實施例證實,仙茅萃取物具有皮膚美白及保護DNA等之活性,故可應用於製備具有皮膚美白及保護DNA活性等之化妝品組成物或醫藥組成物的用途。 In summary, it is demonstrated by the above several examples that Curculio curculata extract has skin whitening and DNA protection activities, so it can be applied to the preparation of skin whitening and DNA protection activities such as cosmetic or pharmaceutical compositions. .

需補充的是,本發明雖以特定的製程、特定的分析方法或特定儀器作為例示,說明本發明之仙茅萃取物用於製備具有皮膚美白及保護DNA活性之組成物的用途,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於此,在不脫離本發明之精神和範圍內,本發明之仙茅萃取物用於製備具有皮膚美白及保護DNA活性之組成物的用途亦可使用其他製程、其他的分析方法或其他儀器進行。 It should be added that although the present invention takes a specific process, a specific analytical method or a specific instrument as an example to illustrate the use of the curculio extract of the present invention to prepare a composition with skin whitening and DNA protection activities, the present invention Anyone with ordinary knowledge in the technical field knows that the present invention is not limited to this. Without departing from the spirit and scope of the present invention, the curculus extract of the present invention is used to prepare skin whitening and DNA-protecting compositions. The purpose can also be carried out by other processes, other analytical methods or other instruments.

雖然本發明已以數個實施例揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Although the present invention has been disclosed in several embodiments as above, it is not intended to limit the present invention. Anyone with ordinary knowledge in the technical field to which the present invention belongs can make various modifications without departing from the spirit and scope of the present invention. Modifications and modifications, therefore, the scope of protection of the present invention shall be subject to those defined by the attached patent application scope.

Claims (3)

一種仙茅萃取物用於製備促進皮膚美白、提高清除一氧化氮自由基及保護DNA活性之醫藥組成物的用途,其中該仙茅萃取物係為一正丁醇萃取物,其萃取方法包含:於10℃至不高於40℃利用低級醇溶液對仙茅(Curculigo orchioides)之一塊根或一根莖(rhizomes)進行一粗萃步驟,該塊根或該根莖與該低級醇溶液之一重量體積比(g:mL)為1:500至1:1000,以獲得一粗萃物,且該低級醇溶液為甲醇溶液或乙醇溶液;利用正己烷與水對該粗萃物進行一第一分配萃取步驟,以獲得一正己烷萃取層及一第一水萃取層,其中該正己烷萃取層具有一正己烷萃取物,該正己烷萃取物的總酚量相當於3.1mg/g的沒食子酸當量,該正己烷萃取物的總黃酮量相當於107.2mg/g的芸香苷當量;利用乙酸乙酯對該第一水萃取層進行一第二分配萃取步驟,以獲得一乙酸乙酯萃取層及一第二水萃取層,其中該乙酸乙酯萃取層具有一乙酸乙酯萃取物,該乙酸乙酯萃取物的總酚量相當於32.8mg/g的沒食子酸當量,該乙酸乙酯萃取物的總黃酮量相當於232.6mg/g的芸香苷當量;以及利用正丁醇對該第二水萃取層進行一第三分配萃取步驟,以獲得正丁醇萃取層,其中該正丁醇萃取層具有該正丁醇萃取物,該正丁醇萃取物的總酚量相當於25.5mg/g的沒食子酸當量,該正丁醇萃取物的總黃酮量相當於151.5mg/g的芸香苷當量。 A kind of Curculia vulgaris extract is used to prepare a medicinal composition that promotes skin whitening, improves the elimination of nitric oxide free radicals and protects DNA activity, wherein the Curculia vulgaris extract is a n-butanol extract, and the extraction method includes: A rough extraction step is performed on a tuber or stem (rhizomes) of Curculigo orchioides with a lower alcohol solution at 10°C to no higher than 40°C, and a weight-volume ratio of the tuber or the rhizome to the lower alcohol solution (g:mL) is 1:500 to 1:1000 to obtain a crude extract, and the lower alcohol solution is methanol solution or ethanol solution; the crude extract is subjected to a first partition extraction step using n-hexane and water To obtain a n-hexane extraction layer and a first water extraction layer, wherein the n-hexane extraction layer has a n-hexane extract, and the total phenol content of the n-hexane extract is equivalent to 3.1 mg/g gallic acid equivalent The total amount of flavonoids in the n-hexane extract is equivalent to 107.2 mg/g rutin equivalent; the first water extraction layer is subjected to a second partition extraction step with ethyl acetate to obtain an ethyl acetate extraction layer and a The second water extraction layer, wherein the ethyl acetate extraction layer has an ethyl acetate extract, the total phenol content of the ethyl acetate extract is equivalent to 32.8 mg/g gallic acid equivalent, and the ethyl acetate extract The total amount of flavonoids is equivalent to 232.6mg/g rutin equivalent; and the second water extraction layer is subjected to a third partition extraction step using n-butanol to obtain a n-butanol extraction layer, wherein the n-butanol extraction layer With the n-butanol extract, the total phenol content of the n-butanol extract is equivalent to 25.5mg/g gallic acid equivalent, and the total flavonoid content of the n-butanol extract is equivalent to 151.5mg/g rutin equivalent. 如申請專利範圍第1項所述之用途,其中該仙 茅萃取物之該促進皮膚美白的一有效劑量為25μg/mL至50μg/mL。 For the purposes described in item 1 of the scope of patent application, the cents An effective dose of the extract of cylindrica for promoting skin whitening is 25μg/mL to 50μg/mL. 如申請專利範圍第1項所述之用途,其中該仙茅萃取物之該保護DNA活性的一有效劑量為100μg/mL至500μg/mL。 The use described in item 1 of the scope of patent application, wherein an effective dose of the curculus extract for protecting the DNA activity is 100 μg/mL to 500 μg/mL.
TW107146665A 2018-12-22 2018-12-22 Extract from golden eye-grass (curculigo orchioides) and use in preparation of composition having activities of skin whitening and protecting dna TWI736818B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW107146665A TWI736818B (en) 2018-12-22 2018-12-22 Extract from golden eye-grass (curculigo orchioides) and use in preparation of composition having activities of skin whitening and protecting dna

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW107146665A TWI736818B (en) 2018-12-22 2018-12-22 Extract from golden eye-grass (curculigo orchioides) and use in preparation of composition having activities of skin whitening and protecting dna

Publications (2)

Publication Number Publication Date
TW202023527A TW202023527A (en) 2020-07-01
TWI736818B true TWI736818B (en) 2021-08-21

Family

ID=73005091

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107146665A TWI736818B (en) 2018-12-22 2018-12-22 Extract from golden eye-grass (curculigo orchioides) and use in preparation of composition having activities of skin whitening and protecting dna

Country Status (1)

Country Link
TW (1) TWI736818B (en)

Also Published As

Publication number Publication date
TW202023527A (en) 2020-07-01

Similar Documents

Publication Publication Date Title
DK2538917T3 (en) Composition containing extract of Venus Flycatcher for cosmetic treatment
KR20080097487A (en) Combination or plant extract comprising verbascoside and luteolin and their use in a cosmetically or pharmaceutical composition for pigmentation modulation
KR101145089B1 (en) Topical depigmenting formulations comprising an extract of bellis perennis
KR20150118293A (en) Oriental medicinal herb admixture (Glycyrrhizae Radix, Sopharae Radix, Angelica gigas) by using of multifunctional cosmetic compositions have anti-oxidative, anti-inflammatory, anti-wrinkle and whitening effect
AdamskaSzewczyk et al. Plant polyphenols in cosmetics–a review
JP2003155238A (en) Skin care preparation
TWI736818B (en) Extract from golden eye-grass (curculigo orchioides) and use in preparation of composition having activities of skin whitening and protecting dna
US20100166683A1 (en) Composition of external preparation for uv-protection comprising rehmannia glutinosa extracts
CN110664671B (en) Plant extract composition and application thereof in sunscreen, after-sun repair, photoaging prevention and whitening cosmetics
KR101835356B1 (en) Method for producing extract of Selaginella tamariscina with enhanced extraction yield using ultra high-pressure homogenization
KR20180081327A (en) Composition for skin conditioning comprising Adenophora Stricta extract
KR20170137549A (en) Composition for improving skin condition comprising herb extracts mixture
KR102199858B1 (en) Cosmetic Compositions Comprising Complex Extracts of Oriental Medicinal Herbs
KR20200006883A (en) Composition for protecting or improving UV-induced skin damage comprising the extract of plants as an active ingredient
KR20010038100A (en) Cosmetic compositions for skin whitening containing extract of galenical medicines
JP2005008548A (en) External preparation for skin
KR20110097301A (en) Whitening cosmetic composition containing hippophae rhamnoides extract, low molecular weight fucoidan and niacin amide, and the method for preparing thereof
CN106691879B (en) Application of the traditional Chinese medicine monomer and combinations thereof in sun-proof whitening anti-aging cosmetics
KR101012551B1 (en) Whitening cosmetic composition
KR20030004501A (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20030004499A (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR101521579B1 (en) Skin Whitening and Anti―oxidative Composition Containing Boesenbergia rotunda Extract
TWI711468B (en) Use of boehmeria nivea extract for manufacturing composition for cell protection, skin whitening and anti- wrinkle
KR20160132151A (en) Skin agent composition
KR101922131B1 (en) Composition for skin-whitener containing extract of stauntonia hexaphylla